Display options
Cite
Zhou L, Li SY, Chen C, et al. Hemorrhagic shock after contrast-enhanced ultrasound-guided liver biopsy: A case report of primary hepatic angiosarcoma. J Clin Ultrasound. 2021;doi: 10.1002/jcu.23114.
Zhou, L., Li, S. Y., Chen, C., & Xu, J. (2021). Hemorrhagic shock after contrast-enhanced ultrasound-guided liver biopsy: A case report of primary hepatic angiosarcoma. Journal of clinical ultrasound : JCU, . https://doi.org/10.1002/jcu.23114
Zhou, Ling, et al. "Hemorrhagic shock after contrast-enhanced ultrasound-guided liver biopsy: A case report of primary hepatic angiosarcoma." Journal of clinical ultrasound : JCU vol. (2021). doi: https://doi.org/10.1002/jcu.23114
Zhou L, Li SY, Chen C, Xu J. Hemorrhagic shock after contrast-enhanced ultrasound-guided liver biopsy: A case report of primary hepatic angiosarcoma. J Clin Ultrasound. 2021 Dec 28; doi: 10.1002/jcu.23114. Epub 2021 Dec 28. PMID: 34964135.
Copy Download .nbib Format: NLM
Share it on

J Clin Ultrasound. 2021 Dec 28; doi: 10.1002/jcu.23114. Epub 2021 Dec 28.

Hemorrhagic shock after contrast-enhanced ultrasound-guided liver biopsy: A case report of primary hepatic angiosarcoma.

Journal of clinical ultrasound : JCU

Ling Zhou, Shi-Yan Li, Chao Chen, Jing Xu

Affiliations

  1. Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  2. Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  3. Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China.

PMID: 34964135 DOI: 10.1002/jcu.23114

Abstract

Primary hepatic angiosarcoma (PHA) is a rare, highly aggressive malignancy. There is no specificity in clinical manifestations, laboratory examinations and imaging examinations. The definitive diagnosis of PHA depends on pathological analysis. The gold standard method to obtain specimens is percutaneous transhepatic biopsy under the guidance of contrast-enhanced ultrasound (CEUS). However, CEUS-guided biopsy for PHA is controversial. If a biopsy is necessary, a comprehensive preoperative evaluation is essential. In addition, CEUS has an auxiliary value in diagnosing PHA. In this case, we present an elderly woman who underwent CEUS-guided liver mass biopsy. The patient developed hemorrhagic shock after biopsy.

© 2021 Wiley Periodicals LLC.

Keywords: biopsy; contrast agent BR1; hemangiosarcoma; liver; ultrasonography

References

  1. Minh MT, Mazzola A, Perdigao F, et al. Primary hepatic angiosarcoma and liver transplantation: radiological, surgical, histological findings and clinical outcome. Clin Res Hepatol Gas. 2018;42:17-23. - PubMed
  2. Lazăr DC, Avram MF, Romoșan I, Văcariu V, Goldiș A, Cornianu M. Malignant hepatic vascular tumors in adults: characteristics, diagnostic difficulties and current management. World J Clin Oncol. 2019;10:110-135. - PubMed
  3. Pickhardt PJ, Kitchin D, Lubner MG, Ganeshan DM, Bhalla S, Covey AM. Primary hepatic angiosarcoma: multi-institutional comprehensive cancer Centre review of multiphasic CT and MR imaging in 35 patients. Eur Radiol. 2015;25:315-322. - PubMed
  4. Konstantinidis IT, Nota C, Jutric Z, et al. Primary liver sarcomas in the modern era: resection or transplantation? J Surg Oncol. 2018;117:886-891. - PubMed
  5. Zhu YP, Chen YM, Matro E, et al. Primary hepatic angiosarcoma: a report of two cases and literature review. World J Gastroenterol. 2015;21:6088-6096. - PubMed
  6. Lorentzen T, Nolsøe CP, Ewertsen C, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part I general aspects (long version). Ultraschall Med. 2015;36:E1-E14. - PubMed
  7. Francica G, Meloni MF, de Sio I, et al. Biopsy of liver target lesions under contrast-enhanced ultrasound guidance: a multi-center study. Ultraschall Med. 2018;39:448-453. - PubMed
  8. Jain D. Diagnosis of hepatocellular carcinoma: fine needle aspiration cytology or needle core biopsy. J Clin Gastroenterol. 2002;35:S101-S108. - PubMed
  9. Kang TW, Lee MW, Choi D, et al. Safety of percutaneous biopsy for hepatic Angiosarcoma: results of a multicenter Korean survey. J Vasc Interv Radiol. 2016;27:846-851. - PubMed
  10. Locker GY, Doroshow JH, Zwelling LA, et al. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine. 1979;58:48-64. - PubMed
  11. Wong JW, Bedard YC. Fine-needle aspiration biopsy of hepatic angiosarcoma: report of a case with immunocytochemical findings. Diagn Cytopathol. 1992;8:380-383. - PubMed
  12. Mitsui F, Aikata H, Hashimoto Y, et al. A first case of hepatic angiosarcoma treated with recombinant interleukin-2. Hiroshima J Med Sci. 2011;60:91-96. - PubMed
  13. Miller MD, Sze DY, Padia SA, et al. Response and overall survival for Yttrium-90 radioembolization of hepatic sarcoma: a multicenter retrospective study. J Vasc Interv Radiol. 2018;29:867-873. - PubMed
  14. Ling WW, Qiu TT, Ma L, Lei C, Luo Y. Contrast-enhanced ultrasound in diagnosis of primary hepatic angiosarcoma. J Med Ultrason. 2017;44:267-270. - PubMed
  15. Sun K, Zhu W, Luo Y, Li Y, Zhou X. Transient segmental enhancement of pyogenic liver abscess: a comparison between contrast-enhanced ultrasound and computed tomography. J Comput Assist Tomogr. 2018;42:133-138. - PubMed
  16. Gnarra M, Behr G, Kitajewski A, et al. History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr. 2016;5:273-280. - PubMed
  17. Ferraioli G, Meloni MF. Contrast-enhanced ultrasonography of the liver using SonoVue. Ultrasonography. 2018;37:25-35. - PubMed
  18. Schellhaas B, Strobel D. Tips and tricks in contrast-enhanced ultrasound (CEUS) for the characterization and detection of liver malignancies. Ultraschall Med. 2019;40:404-424. - PubMed

Publication Types

Grant support